Vivus: into single digits Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vivus: into single digits

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (118)	3/7/1998 3:39:00 PM
From: BigKNY3	Read Replies (1) of 1016

Cacaito: <<This is a Pfizer masterpiece, of course Pfizer will never violate the FDA guidelines, they have the experience Leland does not>> Cacaito: What are you implying in your post? That Pfizer provided misinformation for the article or encouraged its publishing by providing journal support via a Zoloft ad? Doctors write poor articles in medical journals every week.... without the encouragement of pharmaceutical companies. Spreading misinformation of Viagra by Pfizer while the product is being reviewed by the FDA does not make any sense to me at all. Why would any company take this type of risk? Good investing! BigKNY3

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next